← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vaxess Technologies, Inc.
Cambridge, MA
$7,892,429
Total funding
8
Grants
Funding over time
peak $2M · FY2015–24$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,636,429 · 7
NSF$256,000 · 1
By mechanism
R44$3,797,088 · 2
SB1$2,845,449 · 1
R43$993,892 · 4
—$256,000 · 1
Investigators at Vaxess Technologies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Microarray Patch for Broadly Protective Seasonal Influenza Vaccination$1,000,000
SB1 · FY2021 · AI
Microarray Patch for Broadly Protective Seasonal Influenza Vaccination$1,000,000
SB1 · FY2022 · AI
Improved Influenza Vaccine Efficacy Through Infection Mimicry$999,900
R44 · FY2021 · AI
Improved Influenza Vaccine Efficacy Through Infection Mimicry$997,500
R44 · FY2020 · AI
Microarray Patch for Broadly Protective Seasonal Influenza Vaccination$845,449
SB1 · FY2023 · AI
Silk-based biospecimen stabilization for exposure assessment diagnostics$749,996
R44 · FY2018 · ES
Silk-based biospecimen stabilization for exposure assessment diagnostics$749,994
R44 · FY2017 · ES
Development of a Needle Free Microarray Patch for Delivery of a GLP-1 Receptor Agonist$335,410
R43 · FY2024 · DK
Improved Influenza Vaccine Efficacy Through Infection Mimicry$299,698
R44 · FY2019 · AI
SBIR Phase I: At home, single dose mRNA vaccine patch (COVID-19)$256,000
· FY2020 · TIP
Silk-based biospecimen stabilization for exposure assessment diagnostics$225,000
R43 · FY2015 · ES
Silk-Based Blood Sample Stabilization for Prostate Cancer Diagnostics$223,416
R43 · FY2016 · CA
Development of a Silk-Stabilized Inactivated Polio Vaccine$210,066
R43 · FY2015 · AI